Sumitomo Pharma America, Inc.
The Associate Director, RBQM, leads risk-based quality management for oncology clinical trials across phases 1-4 at Sumitomo Pharma America. Reporting to the executive level, the role involves overseeing data-driven risk mitigation strategies, facilitating cross-functional collaboration, and supporting inspection readiness.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Sumitomo Pharma America, Inc..
69% above the average for this role